CJC-1295 is a GHRH analog — it signals the pituitary to release growth hormone. Ipamorelin is a selective GHRP (ghrelin-receptor agonist) that triggers GH release through a different receptor. Because they act on separate pathways, together they produce a greater, more natural pulsatile GH release than either alone — the reason our stacking guide rates this pairing strongly synergistic.
Ipamorelin is prized for being selective — it stimulates GH with minimal effect on cortisol and prolactin, unlike older GHRPs (GHRP-2, GHRP-6). That's why it's the usual GHRP half of the stack.
| CJC-1295 (no DAC) | CJC-1295 (with DAC) | |
|---|---|---|
| Half-life | Short | Long (albumin-bound) |
| Effect | More pulsatile | Steadier elevation |
| Pairs with Ipamorelin | Yes (classic) | Yes |
Don't combine the two CJC forms — that's redundant. Pick one GHRH (a CJC form or Tesamorelin) plus one GHRP (Ipamorelin).
For recovery, many pair the GH stack with the healing stack (BPC-157 + TB-500) — the four-part "Wolverine" combination — since those mechanisms don't overlap either.
PepsTracker tracks CJC-1295 (both forms), Ipamorelin, Tesamorelin and the CJC/Ipa blend across all 26 vendors on cost-per-mg with codes applied. Platinum Peptides carries them (incl. a CJC/IPA blend), 15% off with pepstracker15.
CJC-1295 is a GHRH analog and Ipamorelin is a selective GHRP. They stimulate growth hormone through different receptors, so together they produce greater pulsatile GH release than either alone.
DAC (Drug Affinity Complex) binds albumin to extend half-life, giving steadier GH elevation. No-DAC is shorter-acting and more pulsatile. You choose one, not both.
Ipamorelin is preferred because it's selective — it raises GH with minimal cortisol and prolactin effect, unlike GHRP-2 and GHRP-6.